Peter E. Penson

5.1k total citations · 2 hit papers
114 papers, 2.8k citations indexed

About

Peter E. Penson is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter E. Penson has authored 114 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 27 papers in Cardiology and Cardiovascular Medicine and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter E. Penson's work include Lipoproteins and Cardiovascular Health (41 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Peter E. Penson is often cited by papers focused on Lipoproteins and Cardiovascular Health (41 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Peter E. Penson collaborates with scholars based in United Kingdom, Poland and United States. Peter E. Penson's co-authors include Maciej Banach, Amirhossein Sahebkar, Mohsen Mazidi, Peter P. Tóth, Jacek Rysz, Dimitri P. Mikhailidis, Bożena Sosnowska, Željko Reiner, Maria-Corina Șerban and Matteo Pirro and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and European Heart Journal.

In The Last Decade

Peter E. Penson

110 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of statin intolerance: a meta-analysis

2022 255 citations Ibadete Bytyçi, Peter E. Penson et al. European Heart Journal profile →
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis

2023 90 citations Maciej Banach, Stanisław Surma et al. profile →

Peers

Countries citing papers authored by Peter E. Penson

Since Specialization

Citations

This map shows the geographic impact of Peter E. Penson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Penson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Penson more than expected).

Fields of papers citing papers by Peter E. Penson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Penson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Penson. The network helps show where Peter E. Penson may publish in the future.

Co-authorship network of co-authors of Peter E. Penson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Penson. A scholar is included among the top collaborators of Peter E. Penson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Penson. Peter E. Penson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A 360° Perspective on Cardiovascular Prevention: the International Lipid Expert Panel SiMple tIps for the heaLthy hEart (ILEP-SMILE) 2025 ·Archives of Medical Science ·Maciej Banach, Federica Fogacci, Atanas G. Atanasov, Anca Pantea Stoian, Jacek Jerzy Jozwiak, Ibadete Bytyçi, Ivan Pećin, Niki Katsiki, Mohsen Mazidi, Ioanna Gouni-Berthold, Peter E. Penson, Dan Gaiță, Arrigo F.G. Cicero	2
2	Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003–18 2024 ·Age and Ageing ·(unknown), Stephanie L. Harrison, Peter E. Penson, Ashley Akbari, Fatemeh Torabi, Joe Hollinghurst, Daniel Harris, (unknown), Asangaedem Akpan, Julian Halcox, Sarah Rodgers, Gregory Y.H. Lip, Deirdre A. Lane	3
3	Advancements in curcumin-loaded PLGA nanoparticle delivery systems: progressive strategies in cancer therapy 2024 ·Journal of drug targeting ·Sanaz Keshavarz Shahbaz, Khadijeh Koushki, (unknown), Peter E. Penson, Vasily N. Sukhorukov, Prashant Kesharwani, Amirhossein Sahebkar	12
4	4CPS-075 A systematic review of the target pharmacokinetic/pharmacodynamic parameters of antibiotics treating gram-negative infections 2024 ·Section 4: Clinical pharmacy services ·Hai T. Tran, (unknown), Judith C. Madden, Peter E. Penson, (unknown)	1
5	Supermarket/hypermarket opportunistic screening for atrial fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study 2024 ·American Heart Journal ·Ian Jones, Deirdre A. Lane, Robyn Lotto, David Oxborough, Lis Neubeck, Peter E. Penson, (unknown), (unknown), (unknown), Aderonke Ajiboye, (unknown), Gabriela Czanner, Andy Shaw, (unknown), Gregory Y.H. Lip	3
6	The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper. 2023 ·Archives of Medical Science ·Agata Bielecka‐Dąbrowa, Maciej Banach, (unknown), Arrigo F.G. Cicero, Amani Kallel, Raimondas Kubilius, Dimitri P. Mikhailidis, Amirhossein Sahebkar, Anca Pantea Stoian, Dragoş Vinereanu, Peter E. Penson, Stephan von Haehling	7
7	Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP) 2023 ·Progress in Cardiovascular Diseases ·Maciej Banach, Peter E. Penson, Michel Farnier, Zlatko Fras, Gustavs Latkovskis, Ulrich Laufs, Francesco Paneni, Paolo Parini, Matteo Pirro, Željko Reiner, Michal Vráblík, Carlos Escobar	43
8	Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study 2022 ·British Journal of General Practice ·(unknown), Stephanie L. Harrison, Peter E. Penson, Ashley Akbari, Fatemeh Torabi, Joe Hollinghurst, Daniel Harris, (unknown), Asangaedem Akpan, Julian Halcox, Sarah Rodgers, Gregory Y.H. Lip, Deirdre A. Lane	4
9	Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022) 2022 ·Cardiovascular Diabetology ·Maciej Banach, Stanisław Surma, Željko Reiner, Niki Katsiki, Peter E. Penson, Zlatko Fras, Amirhossein Sahebkar, Francesco Paneni, Manfredi Rizzo, John J.P. Kastelein	56
10	CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities 2021 ·Metabolites ·(unknown), Manfredi Rizzo, Zlatko Fras, Borut Jug, Maciej Banach, Peter E. Penson	18
11	Exploring pharmacists’ views surrounding conscientious objection to abortion and implications in practice 2021 ·International Journal of Pharmacy Practice ·Clare Maxwell, (unknown), (unknown), Peter E. Penson, Valerie Fleming	10
12	Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study 2021 ·Journal of Clinical Medicine ·Beata Łabuz-Roszak, Maciej Banach, Michał Skrzypek, Adam Windak, Tomasz Tomasik, Mirosław Mastej, Maciej Tomaszewski, Dimitri P. Mikhailidis, Peter P. Tóth, Alberico L. Catapano, Kausik K. Ray, George Howard, Gregory Y.H. Lip, Fadi J. Charchar, Naveed Sattar, Bryan Williams, Thomas M. MacDonald, Peter E. Penson, Jacek Jerzy Jozwiak, (unknown)	5
13	RNA Silencing in the Management of Dyslipidemias 2021 ·Current Atherosclerosis Reports ·(unknown), Maciej Banach, Peter E. Penson	19
14	Liposome Circulation Time is Prolonged by CD47 Coating 2020 ·Protein and Peptide Letters ·Seyed Mohammad Gheibi Hayat, Mahmoud Reza Jaafari, Mahdi Hatamipour, Peter E. Penson, Amirhossein Sahebkar	24
15	Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic 2020 ·Pharmacological Research ·Maciej Banach, Peter E. Penson, Zlatko Fras, Michal Vráblík, Daniel Pella, Željko Reiner, Seyed Mohammad Nabavi, Amirhossein Sahebkar, Meral Kayıkçıoğlu, Magdalena Daccord	46
16	LDL-C: lower is better for longer—even at low risk 2020 ·BMC Medicine ·Peter E. Penson, Matteo Pirro, Maciej Banach	77
17	Association between telomere length and complete blood count in US adults 2017 ·Archives of Medical Science ·Mohsen Mazidi, Peter E. Penson, Maciej Banach	28
18	Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease 2017 ·Journal of clinical lipidology ·(unknown), Peter E. Penson, Anna Gluba-Brzózka, Jacek Rysz, Maciej Banach	17
19	3104Associations between cardiovascular disease, cancer and very low hdl cholesterol in the reasons for geographical and racial differences in stroke (REGARDS) study 2017 ·European Heart Journal ·Peter E. Penson, D. Leann Long, George Howard, Virginia J. Howard, Steve Jones, (unknown), D.P. Mikhailidis, Paul Muntner, Manfredi Rizzo, D J Rader, (unknown), Amirhossein Sahebkar, (unknown), Maciej Banach, (unknown)	1
20	D-003 (Saccharum officinarum): The forgotten lipid-lowering agent 2016 ·Pharmacological Research ·Kamal Awad, Peter E. Penson, Maciej Banach	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact